Kolexia
Fiteni Frederic Oncologie médicale
Fiteni Frederic
Oncologie médicale
Hôpital Carémeau
Nîmes, France
134 Activités
477 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Adénocarcinome Tumeurs de l'ovaire Carcinome épithélial de l'ovaire Carcinomes Récidive tumorale locale

Collaborateurs

Voir plus
Jacot William
Jacot William
Icm Montpellier, Montpellier, France
Westeel-Kaulek Virginie
Westeel-Kaulek Virginie
Hôpital Jean-Minjoz, Besançon, France
Pivot Xavier
Pivot Xavier
Centre Paul Strauss, Strasbourg, France
Houede Nadine
Houede Nadine
Hôpital Carémeau, Nîmes, France

Industries

Voir plus
Pfizer
20 collaboration(s)
Dernière en 2023
AstraZeneca
12 collaboration(s)
Dernière en 2023
Lilly
12 collaboration(s)
Dernière en 2023
Novartis
12 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
CUPCAKE: Early Detection of Triple Negative Breast Cancer Relapse: a Clinical Utility Phase II Trial
Essai Clinique (Institut Curie)   06 mars 2024
BEAUTIFY-3: Multidisciplinary Care Pathway With Electronic Patient Reported Outcomes (ePRO) Post-operative Follow-up of Breast Cancer Surgery Complications to Optimize Patient Quality of Life
Essai Clinique (CHU Nîmes)   29 février 2024
REPARP: Prospective and Multicentric Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.
Essai Clinique (Artios Pharma Ltd)   26 février 2024
PROLIFE: Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Toxicities in Subjects Undergoing Oral Cancer Therapy
Essai Clinique (CHU Nîmes)   13 novembre 2023
2165P A French overview of electronic patient-reported outcomes use in 2022
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
COG STIM 2: Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer: a Multicenter Randomized Controlled Trial
Essai Clinique (Centre François-Baclesse)   11 septembre 2023
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France.
Bulletin du cancer   31 août 2023
GARNET: A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Essai Clinique (Tesaro)   18 août 2023
Optimal First-Line Medico-Surgical Strategy in Ovarian Cancers: Are We There Yet?
Cancers   10 juillet 2023
Quality of Life with Monoclonal Antibody Therapies for Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Review.
European urology oncology   25 mai 2023